Abstract
Soyfoods are a unique dietary source of isoflavones, which have both hormonal and non-hormonal effects relevant to prostate cancer prevention. In vitro, the main soybean isoflavone, genistein, inhibits prostate cancer cell growth; in animals, most but not all studies show isoflavone-rich soy protein and isolated isoflavones inhibit prostate tumor development. Currently, although only limited epidemiologic data indicate soy intake reduces prostate cancer risk, results from a pilot intervention trial suggest isoflavones may be beneficial to prostate cancer patients. For several reasons, men concerned about their prostate health may consider incorporating soy into their diet. © 2003 International Life Sciences Institute.
| Original language | English |
|---|---|
| Pages (from-to) | 117-131 |
| Number of pages | 15 |
| Journal | Nutrition Reviews |
| Volume | 61 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1 2003 |
ASJC Scopus Subject Areas
- Medicine (miscellaneous)
- Nutrition and Dietetics
Keywords
- Cancer
- Genistein
- Isoflavones
- Prostate
- Review
- Soy
- Isoflavones/therapeutic use
- Humans
- Middle Aged
- Risk Factors
- Rats
- Male
- Glycine max
- Prostatic Neoplasms/etiology
- Animals
- Aged
- Mice
- In Vitro Techniques